247 related articles for article (PubMed ID: 28637080)
1. The Prognostic Importance of Bronchoalveolar Lavage Fluid CXCL9 During Minimal Acute Rejection on the Risk of Chronic Lung Allograft Dysfunction.
Shino MY; Weigt SS; Li N; Derhovanessian A; Sayah DM; Saggar R; Huynh RH; Gregson AL; Ardehali A; Ross DJ; Lynch JP; Elashoff RM; Belperio JA
Am J Transplant; 2018 Jan; 18(1):136-144. PubMed ID: 28637080
[TBL] [Abstract][Full Text] [Related]
2. Impact of Allograft Injury Time of Onset on the Development of Chronic Lung Allograft Dysfunction After Lung Transplantation.
Shino MY; Weigt SS; Li N; Derhovanessian A; Sayah DM; Huynh RH; Saggar R; Gregson AL; Ardehali A; Ross DJ; Lynch JP; Elashoff RM; Belperio JA
Am J Transplant; 2017 May; 17(5):1294-1303. PubMed ID: 27676455
[TBL] [Abstract][Full Text] [Related]
3. Plasma CXCL9 and CXCL10 at allograft injury predict chronic lung allograft dysfunction.
Shino MY; Todd JL; Neely ML; Kirchner J; Frankel CW; Snyder LD; Pavlisko EN; Fishbein GA; Schaenman JM; Mason K; Kesler K; Martinu T; Singer LG; Tsuang W; Budev M; Shah PD; Reynolds JM; Williams N; Robien MA; Palmer SM; Weigt SS; Belperio JA
Am J Transplant; 2022 Sep; 22(9):2169-2179. PubMed ID: 35634722
[TBL] [Abstract][Full Text] [Related]
4. The allograft injury marker CXCL9 determines prognosis of anti-HLA antibodies after lung transplantation.
Shino MY; Zhang Q; Li N; Derhovanessian A; Ramsey A; Saggar R; Britton IN; Amubieya OO; Lari SM; Hickey M; Reed EF; Noble PW; Stripp BR; Fishbein GA; Lynch JP; Ardehali A; Sayah DM; Weigt SS; Belperio JA
Am J Transplant; 2022 Feb; 22(2):565-573. PubMed ID: 34464505
[TBL] [Abstract][Full Text] [Related]
5. Bronchoalveolar lavage cytokine-based risk stratification of minimal acute rejection in clinically stable lung transplant recipients.
Levy L; Huszti E; Ahmed M; Ghany R; Hunter S; Moshkelgosha S; Zhang CYK; Boonstra K; Klement W; Tikkanen J; Singer LG; Keshavjee S; Juvet S; Martinu T
J Heart Lung Transplant; 2021 Dec; 40(12):1540-1549. PubMed ID: 34215500
[TBL] [Abstract][Full Text] [Related]
6. The prognostic importance of CXCR3 chemokine during organizing pneumonia on the risk of chronic lung allograft dysfunction after lung transplantation.
Shino MY; Weigt SS; Li N; Palchevskiy V; Derhovanessian A; Saggar R; Sayah DM; Huynh RH; Gregson AL; Fishbein MC; Ardehali A; Ross DJ; Lynch JP; Elashoff RM; Belperio JA
PLoS One; 2017; 12(7):e0180281. PubMed ID: 28686641
[TBL] [Abstract][Full Text] [Related]
7. CXCR3 ligands are associated with the continuum of diffuse alveolar damage to chronic lung allograft dysfunction.
Shino MY; Weigt SS; Li N; Palchevskiy V; Derhovanessian A; Saggar R; Sayah DM; Gregson AL; Fishbein MC; Ardehali A; Ross DJ; Lynch JP; Elashoff RM; Belperio JA
Am J Respir Crit Care Med; 2013 Nov; 188(9):1117-25. PubMed ID: 24063316
[TBL] [Abstract][Full Text] [Related]
8. Correlation between BAL CXCR3 chemokines and lung allograft histopathologies: A multicenter study.
Shino MY; Li N; Todd JL; Neely ML; Kirchner J; Kopetskie H; Sever ML; Frankel CW; Snyder LD; Pavlisko EN; Martinu T; Singer LG; Tsuang W; Budev M; Shah PD; Reynolds JM; Williams N; Robien MA; Palmer SM; Sam Weigt S; Belperio JA
Am J Transplant; 2021 Oct; 21(10):3401-3410. PubMed ID: 33840162
[TBL] [Abstract][Full Text] [Related]
9. The common rejection module in chronic rejection post lung transplantation.
Sacreas A; Yang JYC; Vanaudenaerde BM; Sigdel TK; Liberto JM; Damm I; Verleden GM; Vos R; Verleden SE; Sarwal MM
PLoS One; 2018; 13(10):e0205107. PubMed ID: 30289917
[TBL] [Abstract][Full Text] [Related]
10. Inflammation on bronchoalveolar lavage cytology is associated with decreased chronic lung allograft dysfunction-free survival.
Greenland NY; Deiter F; Calabrese DR; Hays SR; Kukreja J; Leard LE; Kolaitis NA; Golden JA; Singer JP; Greenland JR
Clin Transplant; 2022 Jun; 36(6):e14639. PubMed ID: 35246990
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Allograft CXCL9 during Respiratory Infection on the Risk of Chronic Lung Allograft Dysfunction.
Shino MY; DerHovanessian A; Sayah DM; Saggar R; Ying Xue Y; Ardehali A; Stripp BR; Ross DJ; Lynch JP; Elashoff RM; Weigt SS; Belperio JA
OBM Transplant; 2018; 2(4):. PubMed ID: 31414076
[TBL] [Abstract][Full Text] [Related]
12. Bronchoalveolar lavage cell immunophenotyping facilitates diagnosis of lung allograft rejection.
Greenland JR; Jewell NP; Gottschall M; Trivedi NN; Kukreja J; Hays SR; Singer JP; Golden JA; Caughey GH
Am J Transplant; 2014 Apr; 14(4):831-40. PubMed ID: 24512389
[TBL] [Abstract][Full Text] [Related]
13. BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients.
Berastegui C; Gómez-Ollés S; Sánchez-Vidaurre S; Culebras M; Monforte V; López-Meseguer M; Bravo C; Ramon MA; Romero L; Sole J; Cruz MJ; Román A
Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28008659
[TBL] [Abstract][Full Text] [Related]
14. Epithelial cell death markers in bronchoalveolar lavage correlate with chronic lung allograft dysfunction subtypes and survival in lung transplant recipients-a single-center retrospective cohort study.
Levy L; Tigert A; Huszti E; Saito T; Mitsakakis N; Moshkelgosha S; Joe B; Boonstra KM; Tikkanen JM; Keshavjee S; Juvet SC; Martinu T
Transpl Int; 2019 Sep; 32(9):965-973. PubMed ID: 31002407
[TBL] [Abstract][Full Text] [Related]
15. Cumulative exposure to gamma interferon-dependent chemokines CXCL9 and CXCL10 correlates with worse outcome after lung transplant.
Neujahr DC; Perez SD; Mohammed A; Ulukpo O; Lawrence EC; Fernandez F; Pickens A; Force SD; Song M; Larsen CP; Kirk AD
Am J Transplant; 2012 Feb; 12(2):438-46. PubMed ID: 22151926
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of bronchoalveolar lavage cell phenotype analyses in the postoperative monitoring of lung transplant recipients.
Reynaud-Gaubert M; Thomas P; Gregoire R; Badier M; Cau P; Sampol J; Giudicelli R; Fuentes P
Eur J Cardiothorac Surg; 2002 Jan; 21(1):60-6. PubMed ID: 11788258
[TBL] [Abstract][Full Text] [Related]
17. Donor-Derived Exosomes With Lung Self-Antigens in Human Lung Allograft Rejection.
Gunasekaran M; Xu Z; Nayak DK; Sharma M; Hachem R; Walia R; Bremner RM; Smith MA; Mohanakumar T
Am J Transplant; 2017 Feb; 17(2):474-484. PubMed ID: 27278097
[TBL] [Abstract][Full Text] [Related]
18. The impact of first untreated subclinical minimal acute rejection on risk for chronic lung allograft dysfunction or death after lung transplantation.
Levy L; Huszti E; Tikkanen J; Ghany R; Klement W; Ahmed M; Husain S; Fiset PO; Hwang D; Keshavjee S; Singer LG; Juvet S; Martinu T
Am J Transplant; 2020 Jan; 20(1):241-249. PubMed ID: 31397939
[TBL] [Abstract][Full Text] [Related]
19. BAL Fluid Eosinophilia Associates With Chronic Lung Allograft Dysfunction Risk: A Multicenter Study.
Todd JL; Weber JM; Kelly FL; Neely ML; Mulder H; Frankel CW; Nagler A; McCrae C; Newbold P; Kreindler J; Palmer SM
Chest; 2023 Sep; 164(3):670-681. PubMed ID: 37003354
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of gene expression profiling of bronchoalveolar lavage cells in acute lung allograft rejection.
Weigt SS; Wang X; Palchevskiy V; Li X; Patel N; Ross DJ; Reynolds J; Shah PD; Danziger-Isakov LA; Sweet SC; Singer LG; Budev M; Palmer S; Belperio JA
J Heart Lung Transplant; 2019 Aug; 38(8):845-855. PubMed ID: 31122726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
